JP2026027477A5 - - Google Patents
Info
- Publication number
- JP2026027477A5 JP2026027477A5 JP2025196675A JP2025196675A JP2026027477A5 JP 2026027477 A5 JP2026027477 A5 JP 2026027477A5 JP 2025196675 A JP2025196675 A JP 2025196675A JP 2025196675 A JP2025196675 A JP 2025196675A JP 2026027477 A5 JP2026027477 A5 JP 2026027477A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- rifabutin
- formulation
- solution
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962899257P | 2019-09-12 | 2019-09-12 | |
| US62/899,257 | 2019-09-12 | ||
| US201962902019P | 2019-09-18 | 2019-09-18 | |
| US62/902,019 | 2019-09-18 | ||
| US201962941160P | 2019-11-27 | 2019-11-27 | |
| US62/941,160 | 2019-11-27 | ||
| JP2022516162A JP7777518B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチンの処置方法、使用および組成物 |
| PCT/IB2020/000648 WO2021048612A1 (en) | 2019-09-12 | 2020-08-03 | Rifabutin treatment methods, uses, and compositions |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516162A Division JP7777518B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチンの処置方法、使用および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026027477A JP2026027477A (ja) | 2026-02-18 |
| JP2026027477A5 true JP2026027477A5 (https=) | 2026-03-05 |
Family
ID=72428294
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516162A Active JP7777518B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチンの処置方法、使用および組成物 |
| JP2025196675A Pending JP2026027477A (ja) | 2019-09-12 | 2025-11-17 | リファブチンの処置方法、使用および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516162A Active JP7777518B2 (ja) | 2019-09-12 | 2020-08-03 | リファブチンの処置方法、使用および組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US12370184B2 (https=) |
| EP (1) | EP4027976B1 (https=) |
| JP (2) | JP7777518B2 (https=) |
| KR (1) | KR20220103697A (https=) |
| CN (4) | CN113015519B (https=) |
| AU (2) | AU2020346414B2 (https=) |
| BR (1) | BR112022004659A2 (https=) |
| CA (1) | CA3154318A1 (https=) |
| DK (1) | DK4027976T3 (https=) |
| ES (1) | ES3056897T3 (https=) |
| FI (1) | FI4027976T3 (https=) |
| HR (1) | HRP20251645T1 (https=) |
| LT (1) | LT4027976T (https=) |
| MX (1) | MX2022003075A (https=) |
| MY (1) | MY210244A (https=) |
| PH (1) | PH12022550606A1 (https=) |
| PL (1) | PL4027976T3 (https=) |
| PT (1) | PT4027976T (https=) |
| RS (1) | RS67627B1 (https=) |
| SI (1) | SI4027976T1 (https=) |
| SM (1) | SMT202500491T1 (https=) |
| WO (1) | WO2021048612A1 (https=) |
| ZA (1) | ZA202203357B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230364065A1 (en) * | 2022-05-16 | 2023-11-16 | BioVersys AG | Antibiotic combination therapies |
| WO2026022215A1 (en) * | 2024-07-23 | 2026-01-29 | BioVersys AG | Lyophilized formulations of rifabutin |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645508B1 (en) | 1999-06-18 | 2003-11-11 | Jivn-Ren Chen | Stable L-ascorbic acid composition |
| CN1775214A (zh) * | 2005-11-18 | 2006-05-24 | 武汉大学 | 利福喷丁、利福平、利福布丁或利福定注射剂及其制备方法 |
| NZ571989A (en) * | 2006-03-23 | 2012-07-27 | Agriculture Victoria Serv Pty | Antimicrobial protein |
| CN101362067A (zh) | 2007-08-06 | 2009-02-11 | 天津科技大学 | 一种微胶囊制备方法 |
| MY158809A (en) * | 2010-09-22 | 2016-11-15 | Craun Res Sdn Bhd | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
| EA016410B1 (ru) * | 2010-11-13 | 2012-04-30 | Ооо "Нпк Наносистема" | Фармацевтическая композиция на основе наночастиц циклодекстрина, содержащих рифабутин, способ ее получения, способ лечения микобактериоза и геликобактерной инфекции (варианты) |
| CA2826192A1 (en) | 2011-01-31 | 2012-08-09 | The Government Of The United States, As Represented By The Secretary Of The Army | Methods and compositions for treating bacterial infections with iron chelators |
| CN102178604B (zh) * | 2011-03-22 | 2014-03-05 | 中国人民解放军第三0九医院 | 凝胶微球制备装置、方法及可注射抗结核药物凝胶微球 |
| RU2015133801A (ru) * | 2014-01-09 | 2017-02-16 | Камус Фарма Пвт. Лтд. | Лиофилизированные составы для парентерального применения |
| WO2016014437A1 (en) * | 2014-07-21 | 2016-01-28 | Hiroaki Serizawa | Ophthalmic compositions of rifamycins and uses thereof |
| US9763996B2 (en) | 2015-01-16 | 2017-09-19 | Northern Antibiotics, Ltd. | Polymyxin derivative and uses thereof |
| WO2016178240A1 (en) * | 2015-05-04 | 2016-11-10 | Gufic Biosciences Limited | A freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof |
| KR20190116320A (ko) | 2017-02-07 | 2019-10-14 | 에스티씨. 유엔엠 | 오래 지속되는 자가 포식 유도를 위한 동위 원소 강화 암브록솔 |
| US11701346B2 (en) | 2018-11-28 | 2023-07-18 | University Of Southern California | Rifabutin for the treatment of acinetobacter baumannii |
-
2020
- 2020-08-03 LT LTEPPCT/IB2020/000648T patent/LT4027976T/lt unknown
- 2020-08-03 SM SM20250491T patent/SMT202500491T1/it unknown
- 2020-08-03 ES ES20768379T patent/ES3056897T3/es active Active
- 2020-08-03 CN CN202080005144.XA patent/CN113015519B/zh active Active
- 2020-08-03 CN CN202510450436.9A patent/CN120267667A/zh active Pending
- 2020-08-03 KR KR1020227012083A patent/KR20220103697A/ko not_active Ceased
- 2020-08-03 MX MX2022003075A patent/MX2022003075A/es unknown
- 2020-08-03 EP EP20768379.8A patent/EP4027976B1/en active Active
- 2020-08-03 BR BR112022004659A patent/BR112022004659A2/pt unknown
- 2020-08-03 CN CN202510450439.2A patent/CN120267668A/zh active Pending
- 2020-08-03 PL PL20768379.8T patent/PL4027976T3/pl unknown
- 2020-08-03 CA CA3154318A patent/CA3154318A1/en active Pending
- 2020-08-03 PH PH1/2022/550606A patent/PH12022550606A1/en unknown
- 2020-08-03 MY MYPI2022001371A patent/MY210244A/en unknown
- 2020-08-03 DK DK20768379.8T patent/DK4027976T3/da active
- 2020-08-03 RS RS20251344A patent/RS67627B1/sr unknown
- 2020-08-03 FI FIEP20768379.8T patent/FI4027976T3/fi active
- 2020-08-03 CN CN202510450433.5A patent/CN120267666A/zh active Pending
- 2020-08-03 JP JP2022516162A patent/JP7777518B2/ja active Active
- 2020-08-03 PT PT207683798T patent/PT4027976T/pt unknown
- 2020-08-03 SI SI202030697T patent/SI4027976T1/sl unknown
- 2020-08-03 HR HRP20251645TT patent/HRP20251645T1/hr unknown
- 2020-08-03 AU AU2020346414A patent/AU2020346414B2/en active Active
- 2020-08-03 WO PCT/IB2020/000648 patent/WO2021048612A1/en not_active Ceased
-
2022
- 2022-03-22 ZA ZA2022/03357A patent/ZA202203357B/en unknown
-
2023
- 2023-09-12 US US18/465,226 patent/US12370184B2/en active Active
-
2025
- 2025-11-17 JP JP2025196675A patent/JP2026027477A/ja active Pending
- 2025-12-17 AU AU2025283482A patent/AU2025283482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026027477A5 (https=) | ||
| US4126680A (en) | Tetracycline antibiotic compositions | |
| JP4009877B2 (ja) | 親脂性に富んだカンプトテシン誘導体治療薬 | |
| US6040330A (en) | Pharmaceutical formulations of taxanes | |
| CS205030B2 (en) | Method of producing of the stabil antibiotic means | |
| JPH1129497A5 (https=) | ||
| CA2540174A1 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| JP2009114208A (ja) | アミオダロン含有非経口溶液 | |
| CN101405032B (zh) | 含有吡啶并（3，2，1-ij）苯并噁二嗪型化合物的抗感染溶液 | |
| WO2016159897A1 (en) | Potassium citrate suspension | |
| JP2019537589A5 (https=) | ||
| JP2002505328A (ja) | 抗潰瘍医薬の硝酸塩 | |
| EP1224188B1 (en) | Nasal delivery composition comprising the methane sulphonate salt of morphine and chitosan | |
| JP2002505276A (ja) | 潰瘍用医薬組成物 | |
| IL155428A (en) | Pharmaceutical drondron composition for administration through blood vessels | |
| HUT67672A (en) | Sparfloxacine solution and process for producing that | |
| HU181693B (en) | Process for producing compositions containing oxytetracyclin | |
| FI4027976T3 (fi) | Rifabutiinikoostumuksia ja valmistusmenetelmä | |
| ES2250427T3 (es) | Composiciones farmaceuticas estabilizadas, y procedimiento para su preparacion, que comprenden un antibiotico y un expectorante. | |
| ES2637521T3 (es) | Formulaciones de aripiprazol | |
| JP4130700B2 (ja) | 抗腫瘍剤含有組成物 | |
| FI57883C (fi) | Foerfarande foer framstaellning av en stabil klortetracyklinloesning | |
| FI82378B (fi) | Foerfarande foer framstaellning av injiserbara oxitetracyklinloesningar. | |
| WO1998019707A1 (en) | Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions | |
| ES3021692T3 (en) | Expectorant compound and preparation method and use thereof |